Hypervirulence and carbapenem resistance: two distinct evolutionary directions that led high-risk Klebsiella pneumoniae clones to epidemic success

References

• Bagley ST. Habitat association of Klebsiella species. Infect Control. 1985;6(2):52–58.
   PubMedGoogle Scholar
• Dao TT, Liebenthal D, Tran TK, et al. Klebsiella pneumoniae oropharyngeal carriage in rural and urban Vietnam and the effect of alcohol consumption. PLoS One. 2014;9(3):e91999.
   PubMed Web of Science ®Google Scholar
• Gorrie CL, Mirceta M, Wick RR, et al. Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients. Clin Infect Dis. 2017;65(2):208–215.
   PubMed Web of Science ®Google Scholar
• Hidalgo L, Gutierrez B, Ovejero CM, et al. Klebsiella pneumoniae sequence type 11 from companion animals bearing ArmA methyltransferase, DHA-1 beta-lactamase, and QnrB4. Antimicrob Agents Chemother. 2013;57(9):4532–4534.
   PubMed Web of Science ®Google Scholar
• Siu LK, Yeh KM, Lin JC, et al. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12(11):881–887.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4):228–236.
   PubMed Web of Science ®Google Scholar
• Shu LB, Lu Q, Sun RH, et al. Prevalence and phenotypic characterization of carbapenem-resistant Klebsiella pneumoniae strains recovered from sputum and fecal samples of ICU patients in Zhejiang Province, China. Infect Drug Resist. 2019;12:11–18.
   PubMed Web of Science ®Google Scholar
• Han JH, Goldstein EJ, Wise J, et al. Epidemiology of carbapenem-resistant Klebsiella pneumoniae in a network of long-term acute care hospitals. Clin Infect Dis. 2017;64(7):839–844.
   PubMed Web of Science ®Google Scholar
• Lee CC, Lee CH, Hong MY, et al. Propensity-matched analysis of the impact of extended-spectrum beta-lactamase production on adults with community-onset Escherichia coli, Klebsiella species, and Proteus mirabilis bacteremia. J Microbiol Immunol Infect. 2018;51(4):519–526.
   PubMedGoogle Scholar
• Quan J, Zhao D, Liu L, et al. High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother. 2017;72(1):273–280.
   PubMed Web of Science ®Google Scholar
• Bialek-Davenet S, Criscuolo A, Ailloud F, et al. Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg Infect Dis. 2014;20(11):1812–1820.
   PubMed Web of Science ®Google Scholar
• Holt KE, Wertheim H, Zadoks RN, et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A. 2015;112(27):E3574–3581.
   PubMed Web of Science ®Google Scholar
• Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev. 2019;32(3):e00001–19.
   PubMed Web of Science ®Google Scholar
• Liu YC, Cheng DL, Lin CL. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med. 1986;146(10):1913–1916.
   PubMedGoogle Scholar
• Wang JH, Liu YC, Lee SS, et al. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis. 1998;26(6):1434–1438.
   PubMed Web of Science ®Google Scholar
• Lok KH, Li KF, Li KK, et al. Pyogenic liver abscess: clinical profile, microbiological characteristics, and management in a Hong Kong hospital. J Microbiol Immunol Infect. 2008;41(6):483–490.
   PubMedGoogle Scholar
• Yeoh KG, Yap I, Wong ST, et al. Tropical liver abscess. Postgrad Med J. 1997;73(856):89–92.
   PubMed Web of Science ®Google Scholar
• Chung DR, Lee SS, Lee HR, et al. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect. 2007;54(6):578–583.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao C, Wang Q, et al. High prevalence of hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance. Antimicrob Agents Chemother. 2016;60(10):6115–6120.
   PubMed Web of Science ®Google Scholar
• Fazili T, Sharngoe C, Endy T, et al. Klebsiella pneumoniae liver abscess: an emerging disease. Am J Med Sci. 2016;351(3):297–304.
   PubMed Web of Science ®Google Scholar
• Pastagia M, Arumugam V. Klebsiella pneumoniae liver abscesses in a public hospital in Queens, New York. Travel Med Infect Dis. 2008;6(4):228–233.
   PubMedGoogle Scholar
• Turton JF, Englender H, Gabriel SN, et al. Genetically similar isolates of Klebsiella pneumoniae serotype K1 causing liver abscesses in three continents. J Med Microbiol. 2007;56(Pt 5):593–597.
   PubMed Web of Science ®Google Scholar
• Rahim GR, Gupta N, Maheshwari P, et al. Monomicrobial Klebsiella pneumoniae necrotizing fasciitis: an emerging life-threatening entity. Clin Microbiol Infect. 2019;25(3):316–323.
   PubMed Web of Science ®Google Scholar
• Cheng DL, Liu YC, Yen MY, et al. Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med. 1991;151(8):1557–1559.
   PubMedGoogle Scholar
• Sheu SJ, Kung YH, Wu TT, et al. Risk factors for endogenous endophthalmitis secondary to Klebsiella pneumoniae liver abscess: 20-year experience in Southern Taiwan. Retina. 2011;31(10):2026–2031.
   PubMed Web of Science ®Google Scholar
• Cubero M, Grau I, Tubau F, et al. Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adults in a teaching hospital in Barcelona, Spain (2007–2013). Clin Microbiol Infect. 2016;22(2):154–160.
   PubMed Web of Science ®Google Scholar
• Lo JZW, Leow JJJ, Ng PLF, et al. Predictors of therapy failure in a series of 741 adult pyogenic liver abscesses. J Hepatobiliary Pancreat Sci. 2015;22(2):156–165.
   Web of Science ®Google Scholar
• Tsai HY, Lee MH, Wan CH, et al. C-reactive protein levels can predict positive 18F-FDG PET/CT findings that lead to management changes in patients with bacteremia. J Microbiol Immunol Infect. 2018;51(6):839–846.
   PubMedGoogle Scholar
• Chang WS, Ho MW, Lin PC, et al. Clinical characteristics, treatments, and outcomes of hematogenous pyogenic vertebral osteomyelitis, 12-year experience from a tertiary hospital in central Taiwan. J Microbiol Immunol Infect. 2018;51(2):235–242.
   PubMedGoogle Scholar
• Shon AS, Bajwa RP, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence. 2013;4(2):107–118.
   PubMed Web of Science ®Google Scholar
• Catalan-Najera JC, Garza-Ramos U, Barrios-Camacho H. Hypervirulence and hypermucoviscosity: two different but complementary Klebsiella spp phenotypes? Virulence. 2017;8(7):1111–1123.
   PubMed Web of Science ®Google Scholar
• Diancourt L, Passet V, Verhoef J, et al. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43(8):4178–4182.
   PubMed Web of Science ®Google Scholar
• Brisse S, Fevre C, Passet V, et al. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One. 2009;4(3):e4982.
   PubMed Web of Science ®Google Scholar
• Liu YM, Li BB, Zhang YY, et al. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China. Antimicrob Agents Chemother. 2014;58(9):5379–5385.
   PubMed Web of Science ®Google Scholar
• Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016;80(3):629–661.
   PubMed Web of Science ®Google Scholar
• Lee IR, Molton JS, Wyres KL, et al. Differential host susceptibility and bacterial virulence factors driving Klebsiella liver abscess in an ethnically diverse population. Sci Rep. 2016;6:29316.
   PubMed Web of Science ®Google Scholar
• Liao CH, Huang YT, Chang CY, et al. Capsular serotypes and multilocus sequence types of bacteremic Klebsiella pneumoniae isolates associated with different types of infections. Eur J Clin Microbiol Infect Dis. 2014;33(3):365–369.
   PubMed Web of Science ®Google Scholar
• Qu TT, Zhou JC, Jiang Y, et al. Clinical and microbiological characteristics of Klebsiella pneumoniae liver abscess in East China. BMC Infect Dis. 2015;15:161.
   PubMed Web of Science ®Google Scholar
• Lam MMC, Wyres KL, Duchene S, et al. Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global dissemination. Nat Commun. 2018;9(1):2703.
   PubMed Web of Science ®Google Scholar
• Chen Y-T, Chang H-Y, Lai Y-C, et al. Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43. Gene. 2004;337:189–198.
   Web of Science ®Google Scholar
• Lam MMC, Wick RR, Wyres KL, et al. Genetic diversity, mobilisation and spread of the yersiniabactin-encoding mobile element ICEKp in Klebsiella pneumoniae populations. Microb Genom. 2018;4(9):e000196.
   Web of Science ®Google Scholar
• Lin TL, Lee CZ, Hsieh PF, et al. Characterization of integrative and conjugative element ICEKp1-associated genomic heterogeneity in a Klebsiella pneumoniae strain isolated from a primary liver abscess. J Bacteriol. 2008;190(2):515–526.
   PubMed Web of Science ®Google Scholar
• Lai YC, Lin AC, Chiang MK, et al. Genotoxic Klebsiella pneumoniae in Taiwan. PLoS One. 2014;9(5):e96292.
   PubMed Web of Science ®Google Scholar
• Chen IL, Chiu NC, Chi H, et al. Changing of bloodstream infections in a medical center neonatal intensive care unit. J Microbiol Immunol Infect. 2017;50(4):514–520.
   PubMedGoogle Scholar
• Wyres KL, Wick RR, Gorrie C, et al. Identification of Klebsiella capsule synthesis loci from whole genome data. Microb Genom. 2016;2(12):e000102.
   PubMed Web of Science ®Google Scholar
• Wick RR, Heinz E, Holt KE, et al. Kaptive web: user-friendly capsule and lipopolysaccharide serotype prediction for Klebsiella Genomes. J Clin Microbiol. 2018;56(6):e00197–18.
   PubMed Web of Science ®Google Scholar
• Chiu CH, Wang YC, Yeh KM, et al. Influence of ethanol concentration in the phagocytic function of neutrophils against Klebsiella pneumoniae isolates in an experimental model. J Microbiol Immunol Infect. 2018;51(1):64–69.
   PubMedGoogle Scholar
• Lee CH, Chang CC, Liu JW, et al. Sialic acid involved in hypermucoviscosity phenotype of Klebsiella pneumoniae and associated with resistance to neutrophil phagocytosis. Virulence. 2014;5(6):673–679.
   PubMed Web of Science ®Google Scholar
• Wu JH, Wu AM, Tsai CG, et al. Contribution of fucose-containing capsules in Klebsiella pneumoniae to bacterial virulence in mice. Exp Biol Med (Maywood). 2008;233(1):64–70.
   PubMed Web of Science ®Google Scholar
• Athamna A, Ofek I, Keisari Y, et al. Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect Immun. 1991;59(5):1673–1682.
   PubMed Web of Science ®Google Scholar
• Cheng HY, Chen YS, Wu CY, et al. RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43. J Bacteriol. 2010;192(12):3144–3158.
   PubMed Web of Science ®Google Scholar
• Hsu CR, Lin TL, Chen YC, et al. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited. Microbiology. 2011;157(Pt 12):3446–3457.
   PubMedGoogle Scholar
• Tang HL, Chiang MK, Liou WJ, et al. Correlation between Klebsiella pneumoniae carrying pLVPK-derived loci and abscess formation. Eur J Clin Microbiol Infect Dis. 2010;29(6):689–698.
   PubMed Web of Science ®Google Scholar
• Goetz DH, Holmes MA, Borregaard N, et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002;10(5):1033–1043.
   PubMed Web of Science ®Google Scholar
• Hsieh PF, Lin TL, Lee CZ, et al. Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis. 2008;197(12):1717–1727.
   PubMed Web of Science ®Google Scholar
• Russo TA, Olson R, Macdonald U, et al. Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae. Infect Immun. 2014;82(6):2356–2367.
   PubMed Web of Science ®Google Scholar
• Cuevas-Ramos G, Petit CR, Marcq I, et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A. 2010;107(25):11537–11542.
   PubMed Web of Science ®Google Scholar
• Nougayrede JP, Homburg S, Taieb F, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313(5788):848–851.
   PubMed Web of Science ®Google Scholar
• Lin AC, Liao TL, Lin YC, et al. Complete genome sequence of Klebsiella pneumoniae 1084, a hypermucoviscosity-negative K1 clinical strain. J Bacteriol. 2012;194(22):6316.
   PubMed Web of Science ®Google Scholar
• Arthur JC, Perez-Chanona E, Muhlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338(6103):120–123.
   PubMed Web of Science ®Google Scholar
• Lu MC, Chen YT, Chiang MK, et al. Colibactin contributes to the hypervirulence of pks(+) K1 CC23 Klebsiella pneumoniae in mouse meningitis infections. Front Cell Infect Microbiol. 2017;7:103.
   PubMed Web of Science ®Google Scholar
• Wu KM, Li LH, Yan JJ, et al. Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis. J Bacteriol. 2009;191(14):4492–4501.
   PubMed Web of Science ®Google Scholar
• Tan TY, Ong M, Cheng Y, et al. Hypermucoviscosity, rmpA, and aerobactin are associated with community-acquired Klebsiella pneumoniae bacteremic isolates causing liver abscess in Singapore. J Microbiol Immunol Infect. 2019;52(1):30–34.
   PubMedGoogle Scholar
• Lam MMC, Wyres KL, Judd LM, et al. Tracking key virulence loci encoding aerobactin and salmochelin siderophore synthesis in Klebsiella pneumoniae. Genome Med. 2018;10(1):77.
   PubMedGoogle Scholar
• Passet V, Brisse S. Association of tellurite resistance with hypervirulent clonal groups of Klebsiella pneumoniae. J Clin Microbiol. 2015;53(4):1380–1382.
   PubMed Web of Science ®Google Scholar
• Martin RM, Cao J, Wu W, et al. Identification of pathogenicity-associated loci in Klebsiella pneumoniae from hospitalized patients. mSystems. 2018;3(3):e00015–18.
   PubMed Web of Science ®Google Scholar
• Wyres KL, Holt KE. Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria. Curr Opin Microbiol. 2018;45:131–139.
   PubMed Web of Science ®Google Scholar
• Ramphal R, Ambrose PG. Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis. 2006;42(Suppl4):S164–172.
   PubMedGoogle Scholar
• Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151–1161.
   PubMed Web of Science ®Google Scholar
• Srinivasan A, Patel JB. Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure. Infect Control Hosp Epidemiol. 2008;29(12):1107–1109.
   PubMed Web of Science ®Google Scholar
• van Duin D. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017;8(4):460–469.
   PubMed Web of Science ®Google Scholar
• Lee CM, Lai CC, Chiang HT, et al. Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan. J Microbiol Immunol Infect. 2017;50(2):133–144.
   PubMedGoogle Scholar
• Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785–796.
   PubMed Web of Science ®Google Scholar
• Meatherall BL, Gregson D, Ross T, et al. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med. 2009;122(9):866–873.
   PubMed Web of Science ®Google Scholar
• Kohler PP, Volling C, Green K, et al. Carbapenem resistance, initial antibiotic therapy, and mortality in Klebsiella pneumoniae Bacteremia: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2017;38(11):1319–1328.
   PubMed Web of Science ®Google Scholar
• Sano H, Kobayashi R, Iguchi A, et al. Risk factors for sepsis-related death in children and adolescents with hematologic and malignant diseases. J Microbiol Immunol Infect. 2017;50(2):232–238.
   PubMedGoogle Scholar
• Ting SW, Lee CH, Liu JW. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study. J Microbiol Immunol Infect. 2018;51(5):621–628.
   PubMedGoogle Scholar
• Ku YH, Chen CC, Lee MF, et al. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance. J Microbiol Immunol Infect. 2017;50(6):931–939.
   PubMedGoogle Scholar
• Tang HJ, Lai CC, Chen CC, et al. Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: combination of tigecycline or doxycycline and gentamicin or amikacin. J Microbiol Immunol Infect. 2019;52(2):273–281.
   PubMedGoogle Scholar
• Tumbarello M, Viale P, C V, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55(7):943–950.
   PubMed Web of Science ®Google Scholar
• Tseng SP, Wang SF, Ma L, et al. The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan. J Microbiol Immunol Infect. 2017;50(5):653–661.
   PubMedGoogle Scholar
• Hung YP, Lee JC, Lin HJ, et al. Perceptions of Clostridium difficile infections among infection control professionals in Taiwan. J Microbiol Immunol Infect. 2017;50(4):521–526.
   PubMedGoogle Scholar
• Shields RK, Nguyen MH, Chen L, et al. Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother. 2017;61(8):e00883–17.
   PubMed Web of Science ®Google Scholar
• Dhillon S. Meropenem/vaborbactam: A review in complicated urinary tract infections. Drugs. 2018;78(12):1259–1270.
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Singley CM, Hoover J, et al. Efficacy of cefiderocol against carbapenem-resistant Gram-negative bacilli in immunocompetent-rat respiratory tract infection models recreating human plasma pharmacokinetics. Antimicrob Agents Chemother. 2017;61(9):e00700–17.
   PubMed Web of Science ®Google Scholar
• Petty LA, Henig O, Patel TS, et al. Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae. Infect Drug Resist. 2018;11:1461–1472.
   PubMed Web of Science ®Google Scholar
• Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20(3):440–458.
   PubMed Web of Science ®Google Scholar
• Smith Moland E, Hanson ND, Herrera VL, et al. Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother. 2003;51(3):711–714.
   PubMed Web of Science ®Google Scholar
• Woodford N, Tierno PM Jr., Young K, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother. 2004;48(12):4793–4799.
   PubMed Web of Science ®Google Scholar
• Leavitt A, Navon-Venezia S, Chmelnitsky I, et al. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother. 2007;51(8):3026–3029.
   PubMed Web of Science ®Google Scholar
• Chiu SK, Ma L, Chan MC, et al. Carbapenem nonsusceptible Klebsiella pneumoniae in Taiwan: dissemination and increasing resistance of carbapenemase producers during 2012–2015. Sci Rep. 2018;8(1):8468.
   PubMedGoogle Scholar
• Adams-Haduch JM, Potoski BA, Sidjabat HE, et al. Activity of temocillin against KPC-producing Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother. 2009;53(6):2700–2701.
   PubMed Web of Science ®Google Scholar
• Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53(12):5046–5054.
   PubMed Web of Science ®Google Scholar
• Bushnell G, Mitrani-Gold F, Mundy LM. Emergence of New Delhi metallo-beta-lactamase type 1-producing enterobacteriaceae and non-enterobacteriaceae: global case detection and bacterial surveillance. Int J Infect Dis. 2013;17(5):e325–333.
   PubMed Web of Science ®Google Scholar
• Poirel L, Heritier C, Tolun V, et al. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48(1):15–22.
   PubMed Web of Science ®Google Scholar
• Potron A, Poirel L, Rondinaud E, et al. Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill. 2013;18(31):20549.
   PubMedGoogle Scholar
• Mairi A, Pantel A, Sotto A, et al. OXA-48-like carbapenemases producing Enterobacteriaceae in different niches. Eur J Clin Microbiol Infect Dis. 2018;37(4):587–604.
   PubMed Web of Science ®Google Scholar
• Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012;67(7):1597–1606.
   PubMed Web of Science ®Google Scholar
• Carrer A, Poirel L, Eraksoy H, et al. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother. 2008;52(8):2950–2954.
   PubMed Web of Science ®Google Scholar
• Giani T, Conte V, Di Pilato V, et al. Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative. Antimicrob Agents Chemother. 2012;56(4):2211–2213.
   PubMed Web of Science ®Google Scholar
• Potron A, Nordmann P, Rondinaud E, et al. A mosaic transposon encoding OXA-48 and CTX-M-15: towards pan-resistance. J Antimicrob Chemother. 2012;68(2):476–477.
   PubMed Web of Science ®Google Scholar
• Giske CG, Froding I, Hasan CM, et al. Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom. Antimicrob Agents Chemother. 2012;56(5):2735–2738.
   PubMed Web of Science ®Google Scholar
• Cubero M, Cuervo G, Dominguez MA, et al. Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital. BMC Microbiol. 2015;15:177.
   PubMed Web of Science ®Google Scholar
• Lascols C, Peirano G, Hackel M, et al. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother. 2013;57(1):130–136.
   PubMed Web of Science ®Google Scholar
• Chen L, Mathema B, Chavda KD, et al. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol. 2014;22(12):686–696.
   PubMed Web of Science ®Google Scholar
• D’Costa VM, King CE, Kalan L, et al. Antibiotic resistance is ancient. Nature. 2011;477(7365):457–461.
   PubMed Web of Science ®Google Scholar
• Naas T, Cuzon G, Villegas MV, et al. Genetic structures at the origin of acquisition of the beta-lactamase blaKPC gene. Antimicrob Agents Chemother. 2008;52(4):1257–1263.
   PubMed Web of Science ®Google Scholar
• Sarno R, McGillivary G, Sherratt DJ, et al. Complete nucleotide sequence of Klebsiella pneumoniae multiresistance plasmid pJHCMW1. Antimicrob Agents Chemother. 2002;46(11):3422–3427.
   PubMed Web of Science ®Google Scholar
• Chen L, Chavda KD, Melano RG, et al. Comparative genomic analysis of KPC-encoding pKpQIL-like plasmids and their distribution in New Jersey and New York Hospitals. Antimicrob Agents Chemother. 2014;58(5):2871–2877.
   PubMed Web of Science ®Google Scholar
• Wang LH, Wei DD, Wan LG, et al. Diversity of the genetic environment of the blaKPC-2 gene among Klebsiella pneumoniae clinical isolates in a Chinese hospital. Microb Drug Resist. 2016;22(1):15–21.
   PubMed Web of Science ®Google Scholar
• Adler A, Khabra E, Chmelnitsky I, et al. Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone. Diagn Microbiol Infect Dis. 2014;78(1):12–15.
   PubMed Web of Science ®Google Scholar
• Dong N, Zhang R, Liu L, et al. Genome analysis of clinical multilocus sequence Type 11 Klebsiella pneumoniae from China. Microb Genom. 2018;4:e000149.
   Web of Science ®Google Scholar
• Wyres KL, Gorrie C, Edwards DJ, et al. Extensive capsule locus variation and large-scale genomic recombination within the Klebsiella pneumoniae clonal group 258. Genome Biol Evol. 2015;7(5):1267–1279.
   PubMed Web of Science ®Google Scholar
• Wyres KL, Wick RR, Judd LM, et al. Distinct evolutionary dynamics of horizontal gene transfer in drug resistant and virulent clones of Klebsiella pneumoniae. PLoS Genet. 2019;15(4):e1008114.
   PubMed Web of Science ®Google Scholar
• Lu MC, Tang HL, Chiou CS, et al. Clonal dissemination of carbapenemase-producing Klebsiella pneumoniae: two distinct sub-lineages of sequence type 11 carrying blaKPC-2 and blaOXA-48. Int J Antimicrob Agents. 2018;52(5):658–662.
   PubMed Web of Science ®Google Scholar
• Kim JO, Song SA, Yoon EJ, et al. Outbreak of KPC-2-producing Enterobacteriaceae caused by clonal dissemination of Klebsiella pneumoniae ST307 carrying an IncX3-type plasmid harboring a truncated Tn4401a. Diagn Microbiol Infect Dis. 2017;87(4):343–348.
   PubMed Web of Science ®Google Scholar
• Hamzaoui Z, Ocampo-Sosa A, Maamar E, et al. An outbreak of NDM-1-producing Klebsiella pneumoniae, associated with OmpK35 and OmpK36 porin loss in Tunisia. Microb Drug Resist. 2018;24(8):1137–1147.
   PubMed Web of Science ®Google Scholar
• Giddins MJ, Macesic N, Annavajhala MK, et al. Successive emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in blaKPC-2-harboring Klebsiella pneumoniae sequence type 307 isolates. Antimicrob Agents Chemother. 2018;62(3):e02101–17.
   PubMed Web of Science ®Google Scholar
• Long SW, Olsen RJ, Eagar TN, et al. Population genomic analysis of 1,777 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates, Houston, Texas: unexpected abundance of clonal group 307. MBio. 2017;8(3):e00489–00417.
   PubMed Web of Science ®Google Scholar
• Wyres KL, Hawkey J, Hetland MAK, et al. Emergence and rapid global dissemination of CTX-M-15-associated Klebsiella pneumoniae strain ST307. J Antimicrob Chemother. 2018;74(3):577–581.
   Web of Science ®Google Scholar
• Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2018;18(1):37–46.
   PubMed Web of Science ®Google Scholar
• Yao B, Xiao X, Wang F, et al. Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China. Int J Infect Dis. 2015;37:107–112.
   PubMed Web of Science ®Google Scholar
• Karlsson M, Stanton RA, Ansari U, et al. Identification of a carbapenemase-producing hypervirulent Klebsiella pneumoniae isolate, United States. Antimicrob Agents Chemother. 2019;63(7):e00519.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Pitout JD. Recent advances in the laboratory detection of carbapenemase-producing Enterobacteriaceae. Expert Rev Mol Diagn. 2016;16(7):783–794.
   PubMed Web of Science ®Google Scholar
• Banerjee R, Humphries R. Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae. Virulence. 2017;8(4):427–439.
   PubMed Web of Science ®Google Scholar
• Miller S, Humphries RM. Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae. Expert Rev Anti Infect Ther. 2016;14(8):705–717.
   PubMed Web of Science ®Google Scholar
• Russo TA, Olson R, Fang CT, et al. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol. 2018;56(9):e00776–00718.
   PubMed Web of Science ®Google Scholar
• Yu F, Lv J, Niu S, et al. Multiplex PCR analysis for rapid detection of Klebsiella pneumoniae Carbapenem-Resistant (sequence type 258 [ST258] and ST11) and hypervirulent (ST23, ST65, ST86, and ST375) strains. J Clin Microbiol. 2018;56(9):e00731–18.
   PubMed Web of Science ®Google Scholar
• Huang YT, Jiang JY, Hsu MS, et al. The prevalence of rectal carriage of Klebsiella pneumoniae amongst diabetic patients and their clinical relevance in Taiwan: a five-year prospective study. J Microbiol Immunol Infect. 2018;51(4):510–518.
   PubMedGoogle Scholar
• Yang JJ, Wang JT, Cheng A, et al. Impact of broad-spectrum antimicrobial treatment on the ecology of intestinal flora. J Microbiol Immunol Infect. 2018;51(5):681–687.
   PubMedGoogle Scholar
• Bowers JR, Lemmer D, Sahl JW, et al. KlebSeq, a diagnostic tool for surveillance, detection, and monitoring of Klebsiella pneumoniae. J Clin Microbiol. 2016;54(10):2582–2596.
   PubMed Web of Science ®Google Scholar
• van Dijk EL, Jaszczyszyn Y, Naquin D, et al. The third revolution in sequencing technology. Trends Genet. 2018;34(9):666–681.
   PubMed Web of Science ®Google Scholar
• Pletzer D, Mansour SC, Wuerth K, et al. New mouse model for chronic infections by Gram-negative bacteria enabling the study of anti-infective efficacy and host-microbe interactions. MBio. 2017;8(1):e00140–17.
   PubMed Web of Science ®Google Scholar